Comparative Evaluation of Clinical Efficacy and Safety of Collagen Laminin–Based Dermal Matrix Combined With Resveratrol Microparticles (Dermalix) and Standard Wound Care for Diabetic Foot Ulcers. (September 2021)
- Record Type:
- Journal Article
- Title:
- Comparative Evaluation of Clinical Efficacy and Safety of Collagen Laminin–Based Dermal Matrix Combined With Resveratrol Microparticles (Dermalix) and Standard Wound Care for Diabetic Foot Ulcers. (September 2021)
- Main Title:
- Comparative Evaluation of Clinical Efficacy and Safety of Collagen Laminin–Based Dermal Matrix Combined With Resveratrol Microparticles (Dermalix) and Standard Wound Care for Diabetic Foot Ulcers
- Authors:
- Çetinkalp, Şevki
Gökçe, Evren Homan
Şimşir, IlgınYıldırım
Tuncay Tanrıverdi, Sakine
Doğan, Fatma
Biray Avcı, Çığır
Eroğlu, İpek
Utku, Tülün
Gündüz, Cumhur
Özer, Özgen - Abstract:
- This is an open, prospective, comparative parallel-arm medical device clinical study of Dermalix (Dx) in diabetic foot wounds. Dx is a 3-dimensional collagen-laminin porous-structured dermal matrix prepared and additionally impregnated with resveratrol-loaded hyaluronic acid and dipalmitoylphosphatidylcholine-based microparticles. The aim was to evaluate the efficacy and safety of Dx, an investigational medical device, in Wagner 1 and 2 wounds in comparison to a standard wound care (SWC) that consists of irrigation and cleaning with sterile saline solution. Forty-eight patients were randomized to receive either SWC or SWC + Dx. A 4-week treatment period was followed by a 2-month follow-up without treatment. The wound area measurement, total collagen, vascular epidermal growth factor, tumor necrosis factor, interleukin 1, caspase 3, glutathione, reduced/oxidized glutathione, and lipid peroxidation levels were evaluated. At the end of 4 weeks, the percentage closures of wounds were determined as 57.82% for Dx, and 26.63% for SWC groups. Dx had a significant effect on tumor necrosis factor, caspase 3, and reduced/oxidized glutathione levels. Dx provided 2 times faster wound healing and decreased oxidative stress. Application of Dx in the first phase of wound would help the wound area heal faster with a safe profile.
- Is Part Of:
- International journal of lower extremity wounds. Volume 20:Number 3(2021)
- Journal:
- International journal of lower extremity wounds
- Issue:
- Volume 20:Number 3(2021)
- Issue Display:
- Volume 20, Issue 3 (2021)
- Year:
- 2021
- Volume:
- 20
- Issue:
- 3
- Issue Sort Value:
- 2021-0020-0003-0000
- Page Start:
- 217
- Page End:
- 226
- Publication Date:
- 2021-09
- Subjects:
- diabetic foot wound -- collagen scaffold -- resveratrol -- laminin -- wound healing -- hyaluronic acid
Leg -- Wounds and injuries -- Periodicals
Wounds and injuries -- Prevention -- Periodicals
Leg -- Ulcers -- Periodicals
Wound healing -- Periodicals
617.584 - Journal URLs:
- http://ijl.sagepub.com/ ↗
http://online.sagepub.com/ ↗ - DOI:
- 10.1177/1534734620907773 ↗
- Languages:
- English
- ISSNs:
- 1534-7346
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 16428.xml